Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study.

CONCLUSION: In this open, prospective study, RTX appeared to be very effective and safe in the treatment of the most severe cases of MC.
PMID: 27161362 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - April 28, 2016 Category: Urology & Nephrology Authors: Roccatello D, Sciascia S, Baldovino S, Rossi D, Alpa M, Naretto C, Di Simone D, Menegatti E Tags: Am J Nephrol Source Type: research